BTL

Adalid Sciences focuses on the development of advanced drug delivery systems specifically designed for genomic medicine. The company specializes in creating novel lipid nanoparticles that enhance the stability and bioavailability of nucleic acid therapeutics. By improving the delivery systems for these drugs, Adalid Sciences aims to increase their therapeutic efficacy while minimizing potential side effects. Through its innovative approach, the company is dedicated to optimizing the performance, safety, and efficacy of drug delivery, thereby contributing to advancements in the field of genomic medicine.